D Linke, L Donix, C Peitzsch,
HHH Erb… - International Journal of …, 2022 - mdpi.com
Docetaxel (DTX) is a mainstay in the treatment of metastatic prostate cancer. Failure of DTX
therapy is often associated with multidrug resistance caused by overexpression of efflux …